Clinical trial Recruiting at 1 site Interventional Ages 18 and up

More Health, Less Diabetes: exercise and education program

Official title: Educational Program for Type 2 Diabetes Prevention With Integrated Physical Exercise: Digital and In-Person Approach

Run by Faculdade de Motricidade Humana · NCT07079722 · Data updated 2026-11-12

This program will test whether supervised online or in-person exercise plus health education over 12 months can lower blood sugar and help prevent type 2 diabetes in adults with prediabetes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorFaculdade de Motricidade Humana
Academic / other
Locations1 site (Lisbon, Lisbon District)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJuly 30, 2026
Study endsDecember 20, 2026
Registry record updatedJuly 23, 2025
Trial IDNCT07079722 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults at high or very high risk on the FINDRISC questionnaire, without diagnostic criteria for diabetes on lab testing, who have internet access, can attend scheduled sessions, and are willing to make lifestyle changes.

Probably not a fit

People who already meet diagnostic criteria for diabetes, are pregnant, cannot use digital devices, or have exercise stress test abnormalities that prevent safe participation may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

More Health, Less Diabetes is a three-arm randomized controlled trial comparing supervised online exercise, supervised in-person exercise, and a control group in adults at high risk for type 2 diabetes. The intervention lasts 12 months with six months of supervised exercise (three times per week) and concurrent educational sessions, followed by a six-month follow-up. The primary outcome is 2-hour glucose from an oral glucose tolerance test, with secondary outcomes including HbA1c, fasting glucose, insulin resistance indices, and cost-effectiveness analyses. The trial is delivered from the Faculty of Human Kinetics in Lisbon and includes both clinical and economic endpoints to inform scalable prevention strategies.

Why it matters

Potential benefit: If successful, the program could lower 2-hour glucose levels, reduce progression to type 2 diabetes, and identify a scalable, cost-effective way to deliver preventive exercise and education.

How similar studies have gone: Large prevention programs such as the Diabetes Prevention Program have shown lifestyle and physical activity interventions can substantially reduce progression to diabetes, but direct evidence comparing supervised online versus in-person exercise in prediabetes is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. High or Very High Risk according to the FINDRISC questionnaire;
2. Analytical confirmation of no diagnostic criteria for Diabetes, following a type 2 Diabetes risk assessment;
3. Committed to making lifestyle changes to manage diabetes;
4. Internet access;
5. Availability to participate in the program as required (schedule, location);

Exclusion Criteria:

1. pregnancy (self-report/medical record);
2. Inability to use digital devices
3. Presence of abnormalities on exercise stress test.

Where it's running

  • Faculty of Human Kinetics
    Lisbon, Lisbon District, Portugal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.